Senior Director, Immuno-Oncology and Inflammation @ Codiak BioSciences (March 2023 - May 2023)
Director @ Codiak BioSciences (December 2020 - February 2023)
Principal Scientist @ Codiak BioSciences (August 2018 - December 2020)
Senior Scientist @ (January 2017 - August 2018)
Scientist @ (November 2014 - December 2016)
Postdoctoral Fellow @ Harvard Medical School- Division of Immunology, Microbiology and Immunobiology D (October 2006 - October 2014)
Dalia Burzyn Education
University of Buenos Aires
PhD (Immunology)
2001-2006
University of Buenos Aires
MS in Biological Sciences
1995-2000
Dalia Burzyn Skills
Discovery
Immuno-Oncology/Inflammation/Autoimmunity
Translational Science
Biomarkers
Team Leadership
Drug Development
Translational Research
Immunology
Animal Models
Flow Cytometry
Autoimmune Diseases
Inflammation
Bioinformatics
Cell Biology
Cell Culture
Molecular Biology
In Vivo
Western Blotting
Biochemistry
In Vitro
qPCR
PCR
Polymerase Chain Reaction (PCR)
Biomarkers
Translational Research
Public Speaking
Data Analysis
Microsoft Office
Management
Project Management
Integration
Polymerase Chain Reaction Pcr
Polymerase Chain Reaction
Dalia Burzyn Summary
Dalia Burzyn, based in Boston, MA, US, is currently a Senior Director, Translational Science at ModeX Therapeutics Inc. Dalia Burzyn brings experience from previous roles at Codiak BioSciences and Jounce Therapeutics, Inc.. Dalia Burzyn holds a 2001 - 2006 PhD in Immunology @ University of Buenos Aires. With a robust skill set that includes Discovery, Immuno-Oncology/Inflammation/Autoimmunity, Translational Science, Biomarkers, Team Leadership and more. Dalia Burzyn has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Dalia Burzyn?
Find contact details for 700 million professionals.